Novel approaches to models of Alzheimer’s disease pathology for drug screening and development

Author： Shaughnessy Laura Chamblin Beth McMahon Lori Nair Ayyappan Thomas Mary Wakefield John Koentgen Frank Ramabhadran Ram

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.24, Iss.1, 2004-02, pp. : 23-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers to advance drug development for Alzheimer’s disease

By Schulman Howard

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 409-415

Future Medicine

Access to resources Recommend Favorite

Cell cultures from animal models of Alzheimer’s disease as a tool for faster screening and testing of drug efficacy

By Trinchese Fabrizio Liu Shumin Ninan Ipe Puzzo Daniela Jacob Joel Arancio Ottavio

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 15-21

Humana Press, Inc

Access to resources Recommend Favorite

Drug discovery: Estrogen-related compounds in mouse models of Alzheimer’s disease

By Smith Jonathan Chakrabarti Enakshi Levin-Allerhand Justine

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 145-147

Humana Press, Inc

Access to resources Recommend Favorite

A New Regulatory Road-Map for Alzheimer’s Disease Drug Development

Current Alzheimer Research, Vol. 11, Iss. 3, 2014-03 ,pp. : 215-220

Bentham Science Publishers

Access to resources Recommend Favorite

Lewy body pathology in Alzheimer’s disease

By Kotzbauer Paul Trojanowski John Lee Virginia

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 225-232

Humana Press, Inc

Access to resources Recommend Favorite